ELOXX PHARMACEUTICALS, INC.

(ELOX)
  Report
Delayed Nasdaq  -  05/20 04:00:01 pm EDT
0.3360 USD   -3.75%
05/10Eloxx Pharmaceuticals Reports First Quarter 2022 Financial and Operating Results and Provides Business Update
GL
05/10Eloxx Pharmaceuticals Reports First Quarter 2022 Financial and Operating Results and Provides Business Update
AQ
05/09HC Wainwright Trims Eloxx Pharmaceuticals Price Target to $0.5 From $1, Maintains Neutral Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on ELOXX PHARMACEUTICALS, INC.
05/09HC Wainwright Trims Eloxx Pharmaceuticals Price Target to $0.5 From $1, Maintains Neutr..
MT
01/24B. Riley Lowers Eloxx Pharmaceuticals' Price Target to $3 from $5 After Revising Cost C..
MT
2021Oppenheimer Initiates Coverage on Eloxx Pharmaceuticals With Outperform Rating, $4 Pric..
MT
2021HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $1 From $2, Keeps Neutral ..
MT
2021HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $2 From $3, Maintains Neut..
MT
2021ELOXX PHARMACEUTICALS : Mizuho Securities Starts Eloxx Pharmaceuticals at Buy With $3.10 P..
MT
2021ELOXX PHARMACEUTICALS : B. Riley Starts Eloxx Pharmaceuticals at Buy with $5 PT, Notes Com..
MT
2021ELOXX PHARMACEUTICALS : Piper Sandler Adjusts Price Target on Eloxx Pharmaceuticals to $4 ..
MT
Upcoming event on ELOXX PHARMACEUTICALS, INC.